Login to Your Account



Pharma: Clinic Roundup


Wednesday, September 4, 2013
• Daiichi Sankyo Co. Ltd., of Tokyo, reported findings from the global Phase III Hokusai-VTE (venous thromboembolism) study of 8,292 patients with acute symptomatic deep vein thrombosis and/or pulmonary embolism.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription